MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202617086328 A) filed by Targed Biopharmaceuticals B. V. on July 14, 2026, for Targeting And Lysing Microthrombi Associated With Aberrant Blood Clotting.
Inventors include De Maat, Steven; and Maas, Coen.
The application for the patent was published on October 09, 2026, under issue no. 41/2026.
Abstract: The present invention provides means and methods for treating MVT and associated and/or similar conditions. The invention therefore provides hybrid proteins for targeted delivery of plasminogen activators to platelet-VWF complexes, or alternatively to the site where these are located, in a fibrin-independent manner. The invention further provides th...